Phase-3 trial of Bharat Biotech's Covaxin commences in AIIMS

Phase-3 trial of Bharat Biotech's Covaxin commences in AIIMS Dr Srivastava was the first one to receive the shot, which would be given to around 15,000 volunteers at the AIIMS over the next few days, sources said. https://ift.tt/eA8V8J